OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Up 6.2% in August

OrthoPediatrics Corp. (NASDAQ:KIDS) saw a large growth in short interest in August. As of August 31st, there was short interest totalling 932,500 shares, a growth of 6.2% from the August 15th total of 878,400 shares. Currently, 5.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 170,800 shares, the short-interest ratio is currently 5.5 days.

Insider Transactions at OrthoPediatrics

In other news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $29.30, for a total value of $293,000.00. Following the completion of the transaction, the general counsel now owns 77,304 shares of the company’s stock, valued at $2,265,007.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 31.80% of the stock is owned by insiders.

Institutional Trading of OrthoPediatrics

A number of large investors have recently modified their holdings of the company. Commonwealth Equity Services LLC grew its position in shares of OrthoPediatrics by 0.6% during the 2nd quarter. Commonwealth Equity Services LLC now owns 72,935 shares of the company’s stock worth $2,098,000 after buying an additional 420 shares in the last quarter. Triodos Investment Management BV increased its holdings in OrthoPediatrics by 1.2% during the second quarter. Triodos Investment Management BV now owns 41,500 shares of the company’s stock valued at $1,194,000 after buying an additional 500 shares during the period. EntryPoint Capital LLC raised its stake in OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock worth $81,000 after buying an additional 1,009 shares in the last quarter. Quest Partners LLC purchased a new position in OrthoPediatrics in the second quarter valued at about $34,000. Finally, Conestoga Capital Advisors LLC raised its stake in shares of OrthoPediatrics by 7.3% during the 1st quarter. Conestoga Capital Advisors LLC now owns 48,653 shares of the company’s stock worth $1,419,000 after acquiring an additional 3,300 shares in the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the company. Needham & Company LLC reiterated a “buy” rating and issued a $42.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th. Truist Financial reaffirmed a “hold” rating and issued a $34.00 price target (up from $30.00) on shares of OrthoPediatrics in a research note on Friday, September 13th. Finally, JMP Securities reissued a “market outperform” rating and set a $50.00 price target on shares of OrthoPediatrics in a research report on Friday, September 13th.

OrthoPediatrics Price Performance

Shares of KIDS stock traded down $0.30 on Wednesday, hitting $30.78. 16,477 shares of the stock traded hands, compared to its average volume of 168,578. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.90 and a quick ratio of 1.96. The firm has a 50 day simple moving average of $30.80 and a two-hundred day simple moving average of $30.20. The firm has a market cap of $733.46 million, a price-to-earnings ratio of -32.30 and a beta of 1.18. OrthoPediatrics has a 52 week low of $23.10 and a 52 week high of $36.23.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Monday, August 5th. The company reported ($0.23) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.31) by $0.08. OrthoPediatrics had a negative net margin of 14.35% and a negative return on equity of 5.44%. The firm had revenue of $52.80 million for the quarter, compared to the consensus estimate of $52.40 million. As a group, equities research analysts predict that OrthoPediatrics will post -0.96 earnings per share for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.